Effects of Fluvoxamine Treatment on the in Vivo Binding of [F-18]FESP in Drug Naive Depressed Patients: A Pet Study

This publication has 69 references indexed in Scilit:

• Pharmacokinetics of Haloperidol
  Clinical Pharmacokinetics, 1999
• In VivoEvidence for the Involvement of Dopamine-D2Receptors in Striatum and Anterior Cingulate Gyrus in Major Depression
  NeuroImage, 1997
• Estrogen control of central neurotransmission: Effect on mood, mental state, and memory
  Cellular and Molecular Neurobiology, 1996
• SSRI differntiation: Pharmacology and pharmacokinetics
  Human Psychopharmacology: Clinical and Experimental, 1995
• Current advances and trends in the treatment of depression
  Trends in Pharmacological Sciences, 1994
• Fluvoxamine
  Drugs, 1993
• Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex
  Brain Research, 1992
• PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
• No-carrier-added 3-(2′-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
• Manipulations of synaptic serotonin: Discrepancy of effects on serotonin S1 and S2 sites
  Life Sciences, 1983